HRP20110568T1 - Postupak priprave agomelatina - Google Patents

Postupak priprave agomelatina

Info

Publication number
HRP20110568T1
HRP20110568T1 HR20110568T HRP20110568T HRP20110568T1 HR P20110568 T1 HRP20110568 T1 HR P20110568T1 HR 20110568 T HR20110568 T HR 20110568T HR P20110568 T HRP20110568 T HR P20110568T HR P20110568 T1 HRP20110568 T1 HR P20110568T1
Authority
HR
Croatia
Prior art keywords
formula
compound
give
subjected
agomelatin
Prior art date
Application number
HR20110568T
Other languages
English (en)
Inventor
Hardouin Christophe
Lecouve Jean-Pierre
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20110568T1 publication Critical patent/HRP20110568T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Postupak za industrijsku sintezu spoja formule (I) naznačen time, da se 3-metoksiacenaftokinon formule (II): izlaže djelovanju jake baze, čime se dobiva spoj formule (III): koji se izlaže uvjetima aminacije, čime se dobiva spoj formule (IV): koji se izlaže djelovanju redukcijskog sustava, čime se dobiva spoj formule (V): koji se zaredom izlaže djelovanju natrijevog acetata i zatim octenog anhidrida, čime se dobiva spoj formule (I), koji se izdvaja u obliku krutine. Patent sadrži još 9 patentnih zahtjeva.
HR20110568T 2008-08-05 2011-08-01 Postupak priprave agomelatina HRP20110568T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804464A FR2934855B1 (fr) 2008-08-05 2008-08-05 Nouveau procede de synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
HRP20110568T1 true HRP20110568T1 (hr) 2011-09-30

Family

ID=40409856

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110568T HRP20110568T1 (hr) 2008-08-05 2011-08-01 Postupak priprave agomelatina

Country Status (46)

Country Link
US (1) US8143449B2 (hr)
EP (1) EP2151429B1 (hr)
JP (1) JP5021004B2 (hr)
KR (1) KR101127357B1 (hr)
CN (1) CN101643431B (hr)
AP (1) AP2509A (hr)
AR (1) AR074887A1 (hr)
AT (1) ATE510816T1 (hr)
AU (1) AU2009202905B2 (hr)
BR (1) BRPI0903045A2 (hr)
CA (1) CA2674764C (hr)
CL (1) CL2009001632A1 (hr)
CR (1) CR10934A (hr)
CU (1) CU23858B1 (hr)
CY (1) CY1111573T1 (hr)
DK (1) DK2151429T3 (hr)
EA (1) EA017684B1 (hr)
EC (1) ECSP099549A (hr)
ES (1) ES2367236T3 (hr)
FR (1) FR2934855B1 (hr)
GE (1) GEP20115344B (hr)
GT (1) GT200900218A (hr)
HK (1) HK1141004A1 (hr)
HN (1) HN2009001435A (hr)
HR (1) HRP20110568T1 (hr)
IL (1) IL199875A (hr)
JO (1) JO2821B1 (hr)
MA (1) MA31830B1 (hr)
ME (1) ME00927B (hr)
MX (1) MX2009007971A (hr)
MY (1) MY144746A (hr)
NI (1) NI200900152A (hr)
NZ (1) NZ578381A (hr)
PE (1) PE20100259A1 (hr)
PL (1) PL2151429T3 (hr)
PT (1) PT2151429E (hr)
RS (1) RS51740B (hr)
SA (1) SA109300498B1 (hr)
SG (1) SG158814A1 (hr)
SI (1) SI2151429T1 (hr)
SV (1) SV2009003344A (hr)
TW (1) TWI376365B (hr)
UA (1) UA106195C2 (hr)
UY (1) UY31985A (hr)
WO (1) WO2010015746A1 (hr)
ZA (1) ZA200905051B (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2011001405A1 (es) 2010-06-10 2012-03-30 Gador S A Conicet Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
CN102531956B (zh) * 2010-12-21 2014-07-09 浙江九洲药业股份有限公司 用于制备阿戈美拉汀的中间体及相关制备方法
US8561395B2 (en) 2011-03-03 2013-10-22 Tenneco Automotive Operating Company Inc. Poka-yoke mounting system for an exhaust treatment device
EP2562151A1 (en) 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
FR3014437B1 (fr) * 2013-12-05 2016-12-23 Servier Lab Nouveau procede de synthese de l'agomelatine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DK0781764T3 (da) * 1994-09-06 2000-07-10 Shionogi & Co Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
SG158814A1 (en) 2010-02-26
ZA200905051B (en) 2010-05-26
ME00927B (me) 2012-06-20
CL2009001632A1 (es) 2010-07-19
NI200900152A (es) 2010-03-25
UY31985A (es) 2010-01-29
CU20090131A7 (es) 2011-05-27
MA31830B1 (fr) 2010-11-01
PE20100259A1 (es) 2010-04-10
GEP20115344B (en) 2011-12-12
US8143449B2 (en) 2012-03-27
SI2151429T1 (sl) 2011-09-30
FR2934855A1 (fr) 2010-02-12
DK2151429T3 (da) 2011-09-19
EA200900943A1 (ru) 2010-04-30
CR10934A (es) 2009-10-15
ATE510816T1 (de) 2011-06-15
AR074887A1 (es) 2011-02-23
JO2821B1 (en) 2014-09-15
AP2009004929A0 (en) 2009-08-31
EA017684B1 (ru) 2013-02-28
MY144746A (en) 2011-10-31
CY1111573T1 (el) 2015-10-07
ES2367236T3 (es) 2011-10-31
ECSP099549A (es) 2010-03-31
CA2674764A1 (fr) 2010-02-05
KR20100017060A (ko) 2010-02-16
FR2934855B1 (fr) 2010-08-13
AU2009202905A1 (en) 2010-02-25
BRPI0903045A2 (pt) 2010-05-25
WO2010015746A1 (fr) 2010-02-11
JP5021004B2 (ja) 2012-09-05
EP2151429B1 (fr) 2011-05-25
TW201018658A (en) 2010-05-16
GT200900218A (es) 2010-08-23
IL199875A0 (en) 2010-05-17
RS51740B (en) 2011-10-31
IL199875A (en) 2013-10-31
SA109300498B1 (ar) 2013-07-23
NZ578381A (en) 2010-11-26
JP2010043078A (ja) 2010-02-25
PT2151429E (pt) 2011-07-11
CU23858B1 (es) 2013-02-26
KR101127357B1 (ko) 2012-04-12
CN101643431A (zh) 2010-02-10
TWI376365B (en) 2012-11-11
AU2009202905B2 (en) 2013-09-05
HN2009001435A (es) 2011-12-27
UA106195C2 (ru) 2014-08-11
CA2674764C (fr) 2012-04-17
AP2509A (en) 2012-11-19
MX2009007971A (es) 2010-03-25
US20100036163A1 (en) 2010-02-11
HK1141004A1 (en) 2010-10-29
PL2151429T3 (pl) 2011-11-30
EP2151429A1 (fr) 2010-02-10
CN101643431B (zh) 2013-05-15
SV2009003344A (es) 2010-02-05

Similar Documents

Publication Publication Date Title
HRP20110568T1 (hr) Postupak priprave agomelatina
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
NZ592497A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
MY156546A (en) Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
NZ599549A (en) Methods of synthesis and purification of heteroaryl compounds
RS53292B (en) CRYSTAL FORMS 2-THIAZOLYL-4-HINOLINYL-OXY DERIVATIVES, POWERFUL HCV INHIBITOR
CY1110893T1 (el) Διαδικασιες και ενδιαμεσες ενωσεις για την παρασκευη ενος μακροκυκλικου αναστολεα πρωτεασης του hcv
TW200640918A (en) Isoxazoline derivative and novel process for its preparation
RS54020B1 (en) ORGANOBOR ESTAR UNITS AND THEIR PHARMACEUTICAL COMPOSITIONS
MX2009003834A (es) Derivados de pirrolidina como inhibidores de iap.
AU2010246749A8 (en) Thiophene derivatives
MY155478A (en) Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
RS52352B (en) NEW AGLOMELATIN SYNTHESIS PROCEDURE
CU24030B1 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
WO2007083090A3 (en) Process for the preparation of uracil derivatives
ME00961B (me) Derivati-7 alkinil-1,8-naftiridoni, njihova priprema i njihova primjena u liječenju
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
NZ597538A (en) Regioselective preparation of 2 -amino-5-trifluoromethylpyrimidine derivatives
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
UA106886C2 (uk) Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та проміжні сполуки магнію
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
RS53772B1 (en) ALISKIREN SYNTHESIS
TW200942520A (en) Heteroannelated anthraquinone derivatives and the synthesis method thereof